Joshua Brody, MD, PhD, of Mount Sinai Hospital, discusses his abstract on Combining In Situ Vaccination with Immune Checkpoint Blockade Induces Long-Term Regression of Lymphoma Tumors at the 58th ASH Annual Meeting in San Diego, CA.
[the_ad id="32629"]